Trastuzumab Rezetecan Followed by Pyrotinib, and Trastuzumab Combined With Capecitabine as First-line Treatment for Advanced HER2-positive Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Retlirafusp Alfa Injection Plus Chemotherapy Versus Investigator's Choice of Anti-PD-1 Antibody Plus Chemotherapy as First-line Treatment for Advanced Gastric Cancer With Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+/HER2- Breast Cancer After Failure of Prior Endocrine Therapy(PANKU-Breast03)
- Status
- RECRUITING
- Phase
- PHASE3
Capecitabine in ER+/HER2-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC
- Status
- RECRUITING
- Phase
- N/A